AMELIVU Trademark

Trademark Overview


On Monday, September 6, 2021, a trademark application was filed for AMELIVU with the United States Patent and Trademark Office. The USPTO has given the AMELIVU trademark a serial number of 79324019. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The AMELIVU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations, for immunoregulation and for the treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the t...
amelivu

General Information


Serial Number79324019
Word MarkAMELIVU
Filing DateMonday, September 6, 2021
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6861677
Registration DateTuesday, October 4, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations, for immunoregulation and for the treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical preparations for the prevention of ocular disorders or diseases; cardiovascular agents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, October 28, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, October 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 3, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, November 23, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, April 8, 2022CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, June 9, 2022ASSIGNED TO EXAMINER
Tuesday, June 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTICE OF PUBLICATION
Wednesday, June 29, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, November 3, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, November 10, 2022FINAL DISPOSITION PROCESSED
Thursday, November 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 26, 2022NOTIFICATION PROCESSED BY IB
Friday, March 21, 2025NEW REPRESENTATIVE AT IB RECEIVED